{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:27:09Z","timestamp":1767961629985,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"46","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.vaccine.2009.06.061","type":"journal-article","created":{"date-parts":[[2009,7,5]],"date-time":"2009-07-05T04:07:00Z","timestamp":1246766820000},"page":"6444-6453","source":"Crossref","is-referenced-by-count":40,"title":["Development of a novel DNA SynCon\u2122 tetravalent dengue vaccine that elicits immune responses against four serotypes"],"prefix":"10.1016","volume":"27","author":[{"given":"Mathura P.","family":"Ramanathan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Chia","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard H.","family":"Selling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niranjan Y.","family":"Sardesai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Joseph","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.06.061_bib1","unstructured":"Centers for Disease Control and Prevention (CDC) DoV-bID-DF. [cited]; available from: http:\/\/cdc.gov\/ncidod\/dvbid\/dengue."},{"key":"10.1016\/j.vaccine.2009.06.061_bib2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.3277268","article-title":"Pathogenesis of Dengue: challenges to molecular biology","volume":"239","author":"Halstead","year":"1988","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.vaccine.2009.06.061_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0966-842X(01)02288-0","article-title":"Epidemic dengue\/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century","volume":"10","author":"Gubler","year":"2002","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2009.06.061_bib4","series-title":"Fields virology","first-page":"991","article-title":"Flaviviridae: the viruses and their replication","author":"Lindenbach","year":"2001"},{"key":"10.1016\/j.vaccine.2009.06.061_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/375291a0","article-title":"The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution","volume":"375","author":"Rey","year":"1995","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.vaccine.2009.06.061_bib6","doi-asserted-by":"crossref","first-page":"7769","DOI":"10.1128\/JVI.75.16.7769-7773.2001","article-title":"Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to vero cells","volume":"75","author":"Crill","year":"2001","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.06.061_bib7","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1128\/JVI.77.4.2600-2606.2003","article-title":"A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites","volume":"77","author":"Lin","year":"2003","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.vaccine.2009.06.061_bib8","doi-asserted-by":"crossref","first-page":"9601","DOI":"10.1128\/JVI.74.20.9601-9609.2000","article-title":"Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site","volume":"74","author":"Mandl","year":"2000","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.06.061_bib9","doi-asserted-by":"crossref","first-page":"4268","DOI":"10.1128\/JVI.75.9.4268-4275.2001","article-title":"Mutational evidence for an internal fusion peptide in flavivirus envelope protein E","volume":"75","author":"Allison","year":"2001","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.061_bib10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.virol.2007.12.032","article-title":"The SARS-CoV ferret model in an infection-challenge study","volume":"374","author":"Chu","year":"2008","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.vaccine.2009.06.061_bib11","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1086\/323395","article-title":"Induction of potent Th1-type immune responses from a novel DNA vaccine for West Nile virus New York isolate (WNV-NY1999)","volume":"184","author":"Yang","year":"2001","journal-title":"J Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2009.06.061_bib12","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.3201\/eid0812.020224","article-title":"Induction of inflammation by West Nile virus capsid through the caspase-9 apoptotic pathway","volume":"8","author":"Yang","year":"2002","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2009.06.061_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4049\/jimmunol.175.1.112","article-title":"Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help","volume":"175","author":"Kutzler","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2009.06.061_bib14","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/13550280500385229","article-title":"Expression and evolutionary analysis of West Nile virus (Merion strain)","volume":"11","author":"Ramanathan","year":"2005","journal-title":"J Neurovirol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.06.061_bib15","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.vaccine.2007.10.041","article-title":"Intradermal\/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques","volume":"26","author":"Hirao","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.06.061_bib16","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/icb.1964.44","article-title":"Enhancement of the infectivity of arboviruses by specific antisera produced in domestic fowls","volume":"42","author":"Hawkes","year":"1964","journal-title":"Aust J Exp Biol Med Sci"},{"key":"10.1016\/j.vaccine.2009.06.061_bib17","first-page":"301","article-title":"Immune enhancement of viral infection","volume":"31","author":"Halstead","year":"1982","journal-title":"Prog Allergy"},{"issue":"6 Suppl","key":"10.1016\/j.vaccine.2009.06.061_bib18","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4269\/ajtmh.2003.69.48","article-title":"Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine","volume":"69","author":"Edelman","year":"2003","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"10.1016\/j.vaccine.2009.06.061_bib19","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.vaccine.2005.09.029","article-title":"Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults","volume":"24","author":"Kitchener","year":"2006","journal-title":"Vaccine"},{"issue":"6 Suppl","key":"10.1016\/j.vaccine.2009.06.061_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.2003.69.6_suppl.0690024","article-title":"Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates","volume":"69","author":"Sun","year":"2003","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.vaccine.2009.06.061_bib21","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1128\/JVI.70.6.4162-4166.1996","article-title":"Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge","volume":"70","author":"Bray","year":"1996","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.06.061_bib22","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1128\/JVI.77.6.3655-3668.2003","article-title":"Yellow fever virus\/dengue-2 virus and yellow fever virus\/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model","volume":"77","author":"Chambers","year":"2003","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.vaccine.2009.06.061_bib23","doi-asserted-by":"crossref","first-page":"11436","DOI":"10.1128\/JVI.77.21.11436-11447.2003","article-title":"Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development","volume":"77","author":"Huang","year":"2003","journal-title":"J Virol"},{"issue":"23","key":"10.1016\/j.vaccine.2009.06.061_bib24","doi-asserted-by":"crossref","first-page":"12907","DOI":"10.1128\/JVI.77.23.12907-12913.2003","article-title":"Replication-defective adenoviral vaccine vector for the induction of immune responses to dengue virus type 2","volume":"77","author":"Jaiswal","year":"2003","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.06.061_bib25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1128\/CDLI.11.2.351-357.2004","article-title":"Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States","volume":"11","author":"Nwanegbo","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.06.061_bib26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0264-410X(97)00215-6","article-title":"Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice","volume":"15","author":"Kochel","year":"1997","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2009.06.061_bib27","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1016\/j.vaccine.2005.11.002","article-title":"Dengue tetravalent DNA vaccine inducing neutralizing antibody and anamnestic responses to four serotypes in mice","volume":"24","author":"Konishi","year":"2006","journal-title":"Vaccine"},{"issue":"11\u201312","key":"10.1016\/j.vaccine.2009.06.061_bib28","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/S0264-410X(99)00376-X","article-title":"A DNA vaccine expressing dengue type 2 virus premembrane and envelope genes induces neutralizing antibody and memory B cells in mice","volume":"18","author":"Konishi","year":"2000","journal-title":"Vaccine"},{"issue":"22","key":"10.1016\/j.vaccine.2009.06.061_bib29","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/S0264-410X(99)00570-8","article-title":"Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein","volume":"18","author":"Raviprakash","year":"2000","journal-title":"Vaccine"},{"issue":"Pt 7","key":"10.1016\/j.vaccine.2009.06.061_bib30","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1099\/0022-1317-81-7-1659","article-title":"Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques","volume":"81","author":"Raviprakash","year":"2000","journal-title":"J Gen Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09008731?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09008731?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T03:34:12Z","timestamp":1589945652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09008731"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":30,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0264410X09008731"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.06.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}